XML 86 R76.htm IDEA: XBRL DOCUMENT
v3.25.1

Commitments and Contingencies - Contingent Consideration (Details) - USD ($) $ in Thousands | Mar. 31, 2025 | Dec. 31, 2024 | Apr. 30, 2024
--- | --- | --- | ---
Commitments And Contingencies |  |  |
Exarafenib milestone contingent consideration | $ 3,307 | $ 3,214 |
CVR Agreement | Kinnate CVR holders |  |  |
Commitments And Contingencies |  |  |
Exarafenib milestone contingent consideration | $ 3,300 |  | $ 2,900

X
- Definition Amount of liability recognized from contingent consideration in asset acquisition, classified as noncurrent. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3 + Details
Name: | us-gaap_AssetAcquisitionContingentConsiderationLiabilityNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Commitments and contingencies. + References No definition available. + Details
Name: | xoma_CommitmentsAndContingenciesLineItems
Namespace Prefix: | xoma_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=xoma_ContingentValueRightsAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=xoma_KinnateCvrHoldersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |